Previous 10 | Next 10 |
Jefferies has assumed coverage of VBI Vaccines (VBIV +0.2%) with a buy rating on the company's "versatile" vaccine technology platform. The firm has a $6 price target on shares (~171% upside based on yesterday's close). Analyst Roger Song says that VBI's platform can provide several large mar...
Israel is set to become the first country in the world to administer a fourth COVID-19 vaccine, which would give "greater protection in the face of Omicron." The first eligible group to receive the vaccine will be people age 60 and older, as well as the immunocompromised and medical personnel...
VBI Vaccines (NASDAQ:VBIV) announces the filing of a New Drug Submission (NDS) to Health Canada for its 3-antigen prophylactic hepatitis B vaccine candidate, seeking approval for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults. VBI’s vaccine ...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the filing of a New Drug Submission (NDS) to Health Canada for the Company’s 3-antigen prophylactic hepatit...
Updated 12-month and 18-month overall survival data demonstrate continued improvements compared to historical controls 1 1 patient remaining on protocol has achieved progression-free survival beyond 86 weeks, demonstrating 93% tumor reduction relative to baseline Data to p...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips December is off to a complicated start for the biotech sector so far. While VBI Vaccines (NASDAQ: VBIV ) has garnered Food and Drug Administration (FDA) approval for a vaccine designed to prevent Hepatitis B, one of...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nubank is in the news today as investors discuss new details from the fintech company’s filing for an initial public offering (IPO). Source: Shutterstock Let’s take a look at what investors need to ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OceanPal (NASDAQ: OP ) stock is riding higher Wednesday on the wave of its public debut yesterday! Source: VladSV / Shutterstock.com Let’s dive into everything traders need to know about OP stock today....
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Since reports of the fast-spreading omicron variant began circulating, coverage has often centered around vaccine producers and their efforts to combat the virus as it manifests in new and unpredictable ways. Many vaccine s...
Applied UV (NASDAQ:AUVI) +47%. Skylight Health Group (NASDAQ:SLHG) +27%. Ardelyx (NASDAQ:ARDX) +18%. IceCure Medical (NASDAQ:ICCM) +17%. Energy Focus (NASDAQ:EFOI) +17%. Ambarella (NASDAQ:AMBA) +15% on Q3 results VBI Vaccines (NASDAQ:VBIV) +14% wins FDA approval for Hepatitis B vacc...
News, Short Squeeze, Breakout and More Instantly...
Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response (PR) and two stable disease (SD) observations have occurred as of May 15, 2024 The partial response, which demonstrated a 67% reduction in tumor size vs. baseline, wa...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the ongoing randomized, controlled Phase 2b study of VBI-1901, the Company’s ca...
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 105% year-over-year in the first quarter of 2024 compared to the first quarter of 2023 Initial encouraging tumor response data from randomized Phase 2b study of VBI-1901 in recurrent glioblastoma (GBM) anno...